164 related articles for article (PubMed ID: 24398956)
21. BMI1 promotes steroidogenesis through maintaining redox homeostasis in mouse MLTC-1 and primary Leydig cells.
Gao T; Lin M; Shao B; Zhou Q; Wang Y; Chen X; Zhao D; Dai X; Shen C; Cheng H; Yang S; Li H; Zheng B; Zhong X; Yu J; Chen L; Huang X
Cell Cycle; 2020 Aug; 19(15):1884-1898. PubMed ID: 32594840
[TBL] [Abstract][Full Text] [Related]
22. miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1.
Yu X; Jiang X; Li H; Guo L; Jiang W; Lu SH
Stem Cells Dev; 2014 Mar; 23(6):576-85. PubMed ID: 24219349
[TBL] [Abstract][Full Text] [Related]
23. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.
Siddique HR; Saleem M
Stem Cells; 2012 Mar; 30(3):372-8. PubMed ID: 22252887
[TBL] [Abstract][Full Text] [Related]
24. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.
Glinsky GV; Berezovska O; Glinskii AB
J Clin Invest; 2005 Jun; 115(6):1503-21. PubMed ID: 15931389
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs and parallel stem cell lives.
Dirks PB
Cell; 2009 Aug; 138(3):423-4. PubMed ID: 19665962
[TBL] [Abstract][Full Text] [Related]
26. miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1.
Zhang Y; Zhou SY; Yan HZ; Xu DD; Chen HX; Wang XY; Wang X; Liu YT; Zhang L; Wang S; Zhou PJ; Fu WY; Ruan BB; Ma DL; Wang Y; Liu QY; Ren Z; Liu Z; Zhang R; Wang YF
Sci Rep; 2016 Feb; 6():19995. PubMed ID: 26847520
[TBL] [Abstract][Full Text] [Related]
27. ShRNA targeting Bmi-1 sensitizes CD44⁺ nasopharyngeal cancer stem-like cells to radiotherapy.
Xu XH; Liu XY; Su J; Li DJ; Huang Q; Lu MQ; Yi F; Ren JH; Chen WH
Oncol Rep; 2014 Aug; 32(2):764-70. PubMed ID: 24927072
[TBL] [Abstract][Full Text] [Related]
28. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
29. Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal M; Lebeau B; Witcher M
Expert Opin Ther Targets; 2019 Jul; 23(7):565-578. PubMed ID: 31177918
[No Abstract] [Full Text] [Related]
30. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.
Gopinath S; Malla R; Alapati K; Gorantla B; Gujrati M; Dinh DH; Rao JS
Carcinogenesis; 2013 Mar; 34(3):550-9. PubMed ID: 23222817
[TBL] [Abstract][Full Text] [Related]
31. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein.
Ma Y; Fu HL; Wang Z; Huang H; Ni J; Song J; Xia Y; Jin WL; Cui DX
Oncotarget; 2017 May; 8(20):33329-33342. PubMed ID: 28415621
[TBL] [Abstract][Full Text] [Related]
32. Unraveling tumor suppressor networks with in vivo RNAi.
Braun CJ; Hemann MT
Cell Stem Cell; 2013 Jun; 12(6):639-41. PubMed ID: 23746971
[TBL] [Abstract][Full Text] [Related]
33. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
Bansal N; Bartucci M; Yusuff S; Davis S; Flaherty K; Huselid E; Patrizii M; Jones D; Cao L; Sydorenko N; Moon YC; Zhong H; Medina DJ; Kerrigan J; Stein MN; Kim IY; Davis TW; DiPaola RS; Bertino JR; Sabaawy HE
Clin Cancer Res; 2016 Dec; 22(24):6176-6191. PubMed ID: 27307599
[TBL] [Abstract][Full Text] [Related]
34. TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence.
Chefetz I; Alvero AB; Holmberg JC; Lebowitz N; Craveiro V; Yang-Hartwich Y; Yin G; Squillace L; Gurrea Soteras M; Aldo P; Mor G
Cell Cycle; 2013 Feb; 12(3):511-21. PubMed ID: 23324344
[TBL] [Abstract][Full Text] [Related]
35. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.
Hu J; Sun F; Chen W; Zhang J; Zhang T; Qi M; Feng T; Liu H; Li X; Xing Y; Xiong X; Shi B; Zhou G; Han B
J Exp Clin Cancer Res; 2019 May; 38(1):227. PubMed ID: 31138311
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.
Nör C; Zhang Z; Warner KA; Bernardi L; Visioli F; Helman JI; Roesler R; Nör JE
Neoplasia; 2014 Feb; 16(2):137-46. PubMed ID: 24709421
[TBL] [Abstract][Full Text] [Related]
37. Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.
Wang XF; Zhang XW; Hua RX; Du YQ; Huang MZ; Liu Y; Cheng YF; Guo WJ
Oncotarget; 2016 Sep; 7(39):63352-63361. PubMed ID: 27542229
[TBL] [Abstract][Full Text] [Related]
38. Side population cells isolated from KATO III human gastric cancer cell line have cancer stem cell-like characteristics.
She JJ; Zhang PG; Wang X; Che XM; Wang ZM
World J Gastroenterol; 2012 Sep; 18(33):4610-7. PubMed ID: 22969237
[TBL] [Abstract][Full Text] [Related]
39. CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways.
Ni SJ; Zhao LQ; Wang XF; Wu ZH; Hua RX; Wan CH; Zhang JY; Zhang XW; Huang MZ; Gan L; Sun HL; Dimri GP; Guo WJ
J Hematol Oncol; 2018 Feb; 11(1):17. PubMed ID: 29422082
[TBL] [Abstract][Full Text] [Related]
40. Stem cells: Self-renewal writ in blood.
Dick JE
Nature; 2003 May; 423(6937):231-3. PubMed ID: 12748623
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
